Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.

Brown DC, Reetz J.

Evid Based Complement Alternat Med. 2012;2012:384301. doi: 10.1155/2012/384301. Epub 2012 Sep 5.

2.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
3.

Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China.

Chang Y, Zhang M, Jiang Y, Liu Y, Luo H, Hao C, Zeng P, Zhang L.

Discov Med. 2017 Apr;23(127):207-219.

5.

Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor.

Mao XW, Archambeau JO, Gridley DS.

Cancer Biother Radiopharm. 1996 Dec;11(6):393-403.

PMID:
10851500
6.

Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review).

Wu JM, Doonan BB, Hsieh TC, Yang Q, Yang XT, Ling MT.

Int J Med Mushrooms. 2016;18(8):651-660. Review.

PMID:
27910783
7.

Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review.

Fritz H, Kennedy DA, Ishii M, Fergusson D, Fernandes R, Cooley K, Seely D.

Integr Cancer Ther. 2015 May;14(3):201-11. doi: 10.1177/1534735415572883. Epub 2015 Mar 17. Review.

PMID:
25784670
8.

Bisphosphonates for breast cancer.

Pavlakis N, Stockler M.

Cochrane Database Syst Rev. 2002;(1):CD003474. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003474.

PMID:
11869664
9.
10.

Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer.

Tsang KW, Lam CL, Yan C, Mak JC, Ooi GC, Ho JC, Lam B, Man R, Sham JS, Lam WK.

Respir Med. 2003 Jun;97(6):618-24.

PMID:
12814145
11.

Activation of peritoneal macrophages by polysaccharopeptide from the mushroom, Coriolus versicolor.

Liu WK, Ng TB, Sze SF, Tsui KW.

Immunopharmacology. 1993 Sep-Oct;26(2):139-46.

PMID:
8282538
12.

[Immunomodulatory and antitumor properties of polysaccharide peptide (PSP)].

Piotrowski J, Jędrzejewski T, Kozak W.

Postepy Hig Med Dosw (Online). 2015 Jan 21;69:91-7. Review. Polish.

PMID:
25614677
13.

A study on immunomodulatory mechanism of Polysaccharopeptide mediated by TLR4 signaling pathway.

Wang Z, Dong B, Feng Z, Yu S, Bao Y.

BMC Immunol. 2015 Jun 2;16:34. doi: 10.1186/s12865-015-0100-5.

14.

Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation.

Mao XW, Green LM, Gridley DS.

Oncology. 2001;61(3):243-53.

PMID:
11574781
15.

Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.

Fisher M, Yang LX.

Anticancer Res. 2002 May-Jun;22(3):1737-54. Review.

PMID:
12168863
16.
17.
18.

Bisphosphonates and other bone agents for breast cancer.

Wong MH, Stockler MR, Pavlakis N.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003474. doi: 10.1002/14651858.CD003474.pub3. Review.

PMID:
22336790
19.

Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice.

Ho JC, Konerding MA, Gaumann A, Groth M, Liu WK.

Life Sci. 2004 Jul 30;75(11):1343-56.

PMID:
15234192
20.

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Nair B, Wilt T, MacDonald R, Rutks I.

Cochrane Database Syst Rev. 2002;(1):CD003506. Review.

PMID:
11869665

Supplemental Content

Support Center